Since 2009, clinical neuroscience researchers have been assigned to the Division 1 CNP&CNS, a name expressing the MHeNs-wide Translational Neuroscience nature of the research program, and the multidisciplinary perspective. With respect to the medical core topics, the focus is upon neurodegeneration of the central nervous system, more specifically Alzheimer’s disease and its prodromal phases, other dementia’s, Vascular Cognitive Impairment, other related cognitive disorders, Parkinson’s disease, peripheral nervous system disease such as small fiber neuropathy, acquired brain damage such as stroke or traumatic brain injuries, MS and epilepsy.
Researchers in the Division investigate the contribution of biological, neuropsychological and psychosocial factors, single and in combination, and the effects of ageing on the normal neurocognitive development, and on mild to severe cognitive dysfunction but also on the progression of neurological diseases itself.
Research in Division 1 is typically conducted in a multi-disciplinary way, with input from the departments of Psychiatry & Neuropsychology, Clinical Neurology, Neuroradiology, Neurophysiology and Otorinolaryngology.
These research questions are translated in our research focussing on cognitive aging, cognitive disorders as well as clinical neuroscience and encompasses the following-interrelated and overlapping-research lines: